Beam gene therapy restores glucose production
Biotechnology company Beam Therapeutics announced that its experimental one-time base editing treatment, BEAM-301, has successfully restored endogenous glucose production in early patients with glycogen storage disease type Ia. Patients in the highest dose cohort safely fasted for 15 hours while reducing cornstarch consumption by up to 92 percent.
Crispr Infusion Cuts Cholesterol in Half for a Full Year
A recent clinical study showed that a single dose of an experimental CRISPR treatment successfully reduced bad cholesterol by over 50% for a full year in heart patients. This promising gene therapy offers a permanent solution that ends patients’ struggles with chronic daily medications.
Scientists engineer yeast to turn plastic into cookies
Researchers at Southern Illinois University Carbondale have successfully used genetic modification techniques to program strains of yeast capable of turning plastic bottle waste and agricultural residue into protein-rich, 3D-printed cookies.